规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | 20S proteasome ↓ ↑ | Proteasome ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ixazomib |
++++
20S proteasome, Ki: 0.93 nM 20S proteasome, IC50: 3.4 nM |
99%+ | |||||||||||||||||
Delanzomib |
+++
Chymotrypsin-like proteasome, IC50: 3.8 nM |
98% | |||||||||||||||||
Celastrol |
+
20S proteasome, IC50: 2.5 μM |
98% | |||||||||||||||||
MLN9708 |
+++
20S proteasome, Ki: 0.93 nM 20S proteasome, IC50: 3.4 nM |
99% | |||||||||||||||||
Bortezomib |
++++
20S proteasome, Ki: 0.6 nM |
98% | |||||||||||||||||
Oprozomib |
++
20S proteasome β5, IC50: 36 nM 20S proteasome LMP7, IC50: 82 nM |
99%+ | |||||||||||||||||
Epoxomicin | ✔ | 99% | |||||||||||||||||
PI-1840 |
++
Chymotrypsin-like proteasome, IC50: 27 nM |
98% | |||||||||||||||||
VR23 |
+++
Chymotrypsin-like proteasomes, IC50: 3 μM Trypsin-like proteasomes, IC50: 1 nM |
99% | |||||||||||||||||
Carfilzomib |
++
Proteasome, IC50: 5 nM |
98% | |||||||||||||||||
(R)-MG-132 |
+
Proteasome, IC50: 100 nM |
98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | Tasisulam, an anticancer agent, induces apoptosis via the intrinsic pathway, resulting in cytochrome c release and caspase-dependent cell death. It also inhibits mitotic progression and induces vascular normalization [1]. |
体外研究 | Tasisulam (200 nM-200 μM; 48 hours) elicits an antiproliferative response across various tumor histologies, with EC50s of 10 μM and 25 μM for Calu-6 and A-375 cell lines, respectively [1]. Tasisulam (25, 50 μM; 72 hours) induces concentration-dependent increases in 4N DNA and G2-M accumulation [1]. Tasisulam induces apoptosis in diverse in vitro cancer cell models within the concentration range of 200 nM to 200 μM over 48 hours [1]. Tasisulam also inhibits VEGF, epidermal growth factor, and fibroblast growth factor-induced endothelial cell cord formation [1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.41mL 0.48mL 0.24mL |
12.05mL 2.41mL 1.20mL |
24.09mL 4.82mL 2.41mL |
CAS号 | 519055-62-0 |
分子式 | C11H6BrCl2NO3S2 |
分子量 | 415.11 |
别名 | 他司磺胺 ;LY 573636 |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place,Inert atmosphere,Room temperature |
溶解方案 |
DMSO: 250 mg/mL(602.25 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |